Predicting mild and moderate&severe symptoms (PUQE) in hyperemesis gravidarum with orexigenic (orexin and galanin) and anorexigenic (aMSH and CART) neuropeptides. This evidence concerns the gene CARTPT and hyperemesis gravidarum.